In vitro apoptotic activity of 2,2-diphenyl-1,3,2-oxazaborolidin-5-ones in L5178Y cells

Life Sciences

Volumn 80, Issue 11, 2007, Pages 1007-1013

  Velasco, Benjamín ^a,b   Trujillo Ferrara, José G ^a   Castillo, Luis H Fabila ^a   Miranda, René ^b   Sánchez Torres, Luvia E ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antineoplastic; Apoptosis; Cytotoxicity; Diphenyloxazaborolidinones; L5178Y cell

Indexed keywords

OXAZABOROLIDINE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; IC 50; IN VITRO STUDY; LEUKEMIA L 5178 Y; MOUSE; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BORON COMPOUNDS; CELL PROLIFERATION; CELL SURVIVAL; DNA FRAGMENTATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; FORMAZANS; INHIBITORY CONCENTRATION 50; LEUKEMIA L5178; MICE; MICE, INBRED BALB C; PHOSPHATIDYLSERINES; TETRAZOLIUM SALTS;

MURINAE;

EID: 33846817385     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.11.034     Document Type: Article

References (32)

1. Adams J., Palpombella V.J., Sausville E.A., Jonson J., and Elliott P.J. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Research 59 (1999) 2615-2622
2. Ascher E., Hanson J.N., Cheng W., Hingorani A., and Scheinman M. Glycine preserves function and decreases necrosis in skeletal muscle undergoing ischemia and reperfusion injury. Surgery 129 2 (2001) 231-235
3. Bursh W., Oberhammer F., and Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends in Pharmacological Sciences 13 (1992) 245-251
4. Chen C.J., Sugiyama K., Kubo H., Huang C., and Makino S. Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase. Journal of Virology 78 19 (2004) 10410-10419
5. Chremos G.N., Weidmann H., and Zimmerman H.K. Preparation and storage of diphenylborinic acid and its anhydride. Journal of Organic Chemistry 26 (1961) 1683
6. Dembitsky V.M., and Srebnik M. Synthesis and biological activity of α-aminoboronic acids, amine-carboxyboranes and their derivatives. Tetrahedon 59 (2003) 579-593
7. Deng L.W., Chiu I., and Strominger J.L. MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proceedings of the National Academy of Sciences of the United States of America 101 3 (2004) 757-762
8. Dobrydneva Y., Abelt C.J., Dovel B., Thadigiri C.M., Williams R.L., and Blackmore P.F. 2-Aminoethoxydiphenyl borate as a prototype drug for a group of structurally related calcium channel blockers in human platelets. Molecular Pharmacology 69 (2006) 247-256
9. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 (2001) 342-348
10. Farfán N., Silva D., and Santillan R. NMR studies of 1,1-diphenylboroxazolidone Derivatives of α-aminoacids. Heteroatom Chemistry 4 6 (1993) 533-536
11. Fischer D.E. Apoptosis in cancer therapy: crossing the threshold. Cell 78 (1994) 539-542
12. Flückiger R., Henson E., Hess G.M., and Gallop P.M. Mass spectral and HPLC analysis of biological compounds with diphenylborinic acid. Biomedical Mass Spectrometry 11 (1984) 611-615
13. Jabbour A., Steinberg D., Dembitsky V.M., Moussaieff A., Zaks B., and Srebnik M. Synthesis and evaluation of oxazaborolidines for antibacterial activity against Streptococcus mutans. Journal of Medicinal Chemistry 47 (2004) 2409-2410
14. Jacob T., Ascher E., Hingorani A., and Kallakuri S. Glycine prevents the induction of apoptosis attributed to mesenteric ischemia/reperfusion injury in a rat model. Surgery 134 3 (2003) 457-466
15. Jacobson M.D., Weil M., and Raff M.C. Programed cell death in animal development. Cell 88 (1997) 347-354
16. Kosower N.S., Kosower E.M., Wertheim B., and Correa W.S. Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide. Biochemical and Biophysical Research Communications 37 (1969) 593-596
17. Lecouer H., Ledru E., Prévost M.C., and Gougeon M.L. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexine-V and 7-AAD citofluorometric staining methods. Journal of Immunological Methods 209 (1997) 111-123
18. Ming-Jie L., Wang Z., Hai-Xia L., Rong-Cong W., Yan-Ze L., and Qing-Yu W. Mitochondrial dysfunction as an early events in the process of apoptosis induced by woodfordin I in human leukemia K562 cells. Toxicology and Applied Pharmacology 194 (2004) 141-155
19. Morin C. The chemistry of boron analogues of biomolecules. Tetrahedron 50 (1994) 12521-12569
20. Sanmartín C., Echeverría M., Mendívil B., Cordeu L., Cubedo E., García-Foncillas J., Font M., and Palop J.A. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers. Bioorganic and Medicinal Chemistry 13 (2005) 2031-2044
21. Schultz D.R., and Harrington W.J. Apoptosis: programmed cell death at molecular level. Seminars in Arthritis and Rheumatism 32 (2003) 345-369
22. Shakibaei M., Schulze-Tanzil G., Takada Y., and Aggarwal B. Redox regulation of apoptosis by members of the TNF superfamily. Antioxidants and Redox Signalling 7 3 (2005) 482-496
23. Soloway A.H., Tjarks W., Barnum B.A., Rong F.-G., Barth R.F., Codogni I.M., and Wilson J.G. The chemistry of neutron capture therapy. Chemical Reviews 98 4 (1998) 1515-1562
24. Tanonaka K., Iwai T., Motegi, Kanataka M., and Takeo S. Effects of N-(2-mercaptopropionyl)-glycine on mitochondrial function in ischemic-reperfusion heart. Cardiovascular Research 57 2 (2002) 416-425
25. Teicher B.A., Ara G., Herbst R., Palombella V.J., and Adams J. The proteasome inhibition PS-341 in cancer therapy. Clinical Cancer Research 5 (1999) 2638-2645
26. Trejo-Solís C., Palencia G., Zúñiga S., Rodríguez-Ropon A., Osorio-Rico L., Sánchez-Torres L., García-Mora I., Márquez-Rosado L., Sánchez A., Moreno-García M.E., Cruz A., Bravo-Gómez M.E., Ruiz-Ramírez L., Rodríguez-Enriquez S., and Sotelo J. Cas IIgly induces apoptosis in glioma C6 cells in vitro and in vivo through caspase-dependent and caspase-independent mechanisms. Neoplasia 7 6 (2005) 563-574
27. Tripathi Y., Hegde B.M., Rai Y.S., and Raghuveer C.V. Effect of N-2-mercaptopropionylglycibe in limiting myocardial reperfusion injury following 90 minutes of ischemia in dogs. Indian Journal of Physiology and Pharmacology 44 (2000) 290-296
28. Trujillo J., Höpfl H., Castillo D., Santillan R., and Farfán N. X-ray crystallographic study of boroxazolidones obtained from l-ornithine, l-methionine, kainic acid and 2,6-pyridinedicarboxylic acid. Journal of Organometallic Chemistry 571 (1998) 21-29
29. Wang C.-L., Li H.-Q., Meng W.-D., and Qing F.-L. Trifluoromethylation of flavonoids and anti-tumor activity of the trifluoromethylated flavonoid derivatives. Bioorganic and Medicinal Chemistry Letters 15 (2005) 4456-4458
30. Wright S.C., Zhong J., and Larrick J.W. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB Journal 8 (1994) 654-660
31. Yan-Jun Z., Kenichi I., Hajime H., Tsuneo K., Yoshiyuki T., and Nobuhiro S. Glycine prevents apoptosis of rat sinusoidal endothelial cells caused by deprivation of vascular endothelial grow factor. Hepatology 32 3 (2000) 542-546
32. Yuan X., Wu J., Shan Y., Yao Z., Dong B., Chen B., Zhao Z., Wang S., Chen J., and Cong Y. SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway. Virology 346 (2006) 74-78